2,2,3,3-tetrafluorooxetane Cas:765-63-9

We are 2,2,3,3-tetrafluorooxetane CAS:765-63-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


2,2,3,3-tetrafluorooxetane

Synonyms:
2,2,3,3-TETRAFLUOROOXETANE
tetrafluorooxetane
2.2.3.3-Tetrafluor-oxetan
2,2,3,3-tetrafluoro-oxetane
2,2,3,3-tetrafluorooxethane
 
Molecular Formula: C3H2F4O
Molecular weight:130.04100
 
 
 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
 



Market News: MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world.N,Nμ,Nμμ-Tri-Boc-guanidine manufacturer.“The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. DL-N-Boc-β-(3-Chlorophenyl)-alanine supplier Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. trityl thiohypochlorite producer

Related Products
Product Name
Benzyl 3-oxoazetidine-1-carboxylate View Details
1H,1H,2H,2H-Perfluorooctyl methacrylate Cas:2144-53-8 View Details
3′,5′-Bis(trifluoromethyl)acetophenone Cas:30071-93-3 View Details
4-methylthiazole manufacturer SPAN 85 Cas:26266-58-0 manufacturer 3,4′-Dichlorodiphenyl ether manufacturer 1-phenoxy-2-propanol Cas:770-35-4 manufacturer (S)-(+)-GLYCIDYL PHTHALIMIDE manufacturer